House Commerce Committee expected to release FDA reform bill by early July.
This article was originally published in The Tan Sheet
Executive Summary
HOUSE COMMERCE COMMITTEE FDA REFORM BILL EXPECTED BY EARLY JULY, using Oversight & Investigations Subcommittee ranking minority member Rep. Ron Wyden's (D-Ore.) "FDA Modernization Act" (HR 1742) as a basis for discussion. Introduced June 6, HR 1742 reflects agreement on both the left and right of the political spectrum on the need for such FDA reforms as increased use of expert panels to speed review of certain drugs; use of independent testing organizations; fewer restrictions on export of U.S.-made products; and separate requirements for approval of drugs and biologics.